Stockscreener 앱 받기
0.00
100.00%
-1.60
Talis Biomedical Corp 주식(TLIS)의 최신 뉴스
TLIS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Los Angeles Daily NewsTalis Biomedical Corporationcommon stock (Nasdaq:TLIS) Stock Quote - FinancialContent
Talis Biomedical Corp (NASDAQ: TLIS)Related Research - intelligentinvestor.com.au
TLIS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Was Filed Against Talis Biomedical Corporation - Newsfile
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Talis Biomedical Corporation (TLIS) Investigation - ACCESS Newswire
TLISTalis Biomedical Corp Latest Stock News & Market Updates - Stock Titan
TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation (NASDAQ: TLIS) - ACCESS Newswire
Eligible Talis Biomedical Investors Could Claim a Share of $32.5 Million Settlement - Claim Depot
Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp - Yahoo Finance
Talis Biomedical Agrees to Settle Investor Suit for $33 Million - Bloomberg Law News
Biotech Investors Reach $32.5M Deal Over Failed COVID Test - Law360
Talis Biomedical ends Chicago office lease with $3.62 millio fee - Investing.com
Talis Biomedical executive buys $44,240 in company stock - Investing.com
Talis Biomedical settles lawsuit with Kriya Therapeutics - Investing.com
TLIS Stock Price and Chart — OTC:TLIS - TradingView — Track All Markets
Talis Biomedical executive buys $641 in stock - Investing.com
Talis Biomedical agrees to $32.5 million settlement - Investing.com
Talis Biomedical to be delisted from Nasdaq on September 3 - Investing.com
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
Talis Biomedical Announces Board Shake-Up Amid Financial Struggles - TipRanks
Press Telegram - FinancialContent
Investors Win Class Cert. Against Failed COVID Test Maker - Law360
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Peninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives' - The Business Journals
Talis Biomedical Corporation Announces Resignation of Felix Baker from the Board of Directors - marketscreener.com
Rustem F. Ismagilov Net Worth (2025) - GuruFocus
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update - FinancialContent
Chemical spill prompts hazmat response, evacuation at Redwood Shores biomedical firm - CBS News
Whittier Daily News - FinancialContent
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) - Stock Titan
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement - FinancialContent
Talis Biomedical Announces 1-for-15 Reverse Stock Split - FinancialContent
Daily Breeze - FinancialContent
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results | About Us | Oil & Gas Journal - FinancialContent
Talis Announces Fourth Quarter and Full Year 2022 Financial Results - GlobeNewswire
2022 Year-End Securities Litigation Update - Gibson Dunn
Billionaire hedge fund manager David Einhorn’s portfolio revealed - Daily Investor
Talis Biomedical Reports Third Quarter 2022 Financial Results - marketscreener.com
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - MarketScreener
Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript - The Motley Fool
MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022 - Yahoo Finance
Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results - GlobeNewswire
Oklahoma City NewsThe Oklahoman - FinancialContent
About Us - FinancialContent
Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022 - Yahoo Finance
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
PRN_FinancialWrapper - FinancialContent
Salt Lake City News, Weather, Sports, Breaking News | KUTVShareholder Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm - FinancialContent
TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
User - FinancialContent
Silicon Valley - FinancialContent
NASDAQ: TLIS Investor Alert: Deadline in Lawsuit for - GlobeNewswire
Investor Action Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm - Markets Financial Content
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm - FinancialContent
FinancialContentROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action TLIS - FinancialContent
NATIONALLY RANKED ROSEN LAW FIRM Encourages Talis - GlobeNewswire
0.11%
자본화:
|
볼륨(24시간):